| Date | Title | Description |
| 04.01.2024 | Alex Therapeutics Reports Positive Results from the Randomiz... | Alex Therapeutics and Vicore Pharma today announced positive results of the COMPANION study, investi... |
| 21.12.2023 | Hadean Ventures announces oversubscribed final close of Hade... | Hadean Ventures announces oversubscribed final close of Hadean Capital II – a fund dedicated to inve... |
| 08.12.2023 | Ribbon Biolabs appoints Jodi Barrientos Chief Executive Offi... | Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer; Founder Harold De Vladar named an a... |
| 09.11.2023 | Complement Therapeutics Enrols First US Participant | Complement Therapeutics Enrols First US Participant in the Non-interventional i-GAIN Study of People... |
| 13.10.2023 | Abliva Achieves Important Milestone in the Ongoing FALCON St... | Abliva AB (Nasdaq Stockholm: ABLI) a clinical-stage company developing drugs for the treatment of ra... |
| 05.09.2023 | Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Desig... | Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Designation
Abliva AB (Nasdaq Stockholm: ABL... |
| 03.05.2023 | ARTHEx Biotech Announces Closing of €42 M Series B Financing... | ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel Treatment ... |
| 17.04.2023 | Complement Therapeutics Secures €72 Million in Series A Fina... | Complement Therapeutics Secures €72 Million in Series A Financing
to Advance Novel Therapies Target... |
| 05.03.2023 | Alex Therapeutics extends financing round to €4.75M with lea... | Innovestor Life Science, a leading biotech and digital health VC, invests €1.25M in the digital ther... |
| 06.12.2022 | Alex Therapeutics and Vicore Pharma today announce the first... | - |
| 24.10.2022 | Step Pharma Announces First Patient Dosed with STP938, the W... | Step Pharma Announces First Patient Dosed with STP938, the World’s Most
Advanced CTPS1 Inhibitor, i... |
| 21.10.2022 | Gesynta Pharma prepares Phase II study of GS-248 in endometr... | 20 October, 2022
Stockholm, Sweden, October 20, 2022 – Gesynta Pharma AB today announces the decisi... |
| 14.10.2022 | Alex Therapeutics presents results from digital therapeutic ... | - |
| 27.07.2022 | Cardior Announces First Patient Dosed in Phase 2 Study | Hanover, Germany, July 20, 2022 – Cardior Pharmaceuticals, a clinical-stage biotech
company develop... |
| 15.07.2022 | Gesynta Pharma completes patient enrollment in its Phase II ... | Stockholm, Sweden, 12 July 2022 –
Gesynta Pharma AB today announces that all patients have
been re... |
| 03.07.2022 | Attgeno AB announces fully subscribed share issue to complet... | Attgeno AB announces that a successful share issue was completed at midsummer 2022 and resulted in S... |
| 30.06.2022 | Vi søker jurist! | Om stillingen
Vi har behov for å styrke vår interne juridiske kompetanse. Som advokat/jurist i Hade... |
| 02.06.2022 | Attgeno announces approval of initiation of Phase 2 clinical... | Attgeno AB today announced that it has received approval from the Swedish Medical Products Agency an... |
| 01.06.2022 | Abliva decides on a SEK 200 million financing to fund Phase ... | - |
| 27.04.2022 | Gesynta Pharma’s drug candidate GS-248 granted Orphan Drug D... | Gesynta Pharma’s drug candidate GS-248 granted Orphan Drug Designation in
US by the FDA for the tre... |
| 06.04.2022 | Alex Therapeutics raises €3.5M in oversubscribed financing r... |
STOCKHOLM, April 6, 2022 /PRNewswire/ — Stockholm-based Digital Therapeutics (DTx) company Alex Th... |
| 22.02.2022 | TargED Biopharmaceuticals raises EUR 39 Million in Series A ... | TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring
groundbreaking throm... |
| 31.01.2022 | Ribbon Biolabs raises EUR 18 million in its Series A financi... | VIENNA, AUSTRIA, January 31, 2022 —
Ribbon Biolabs, the DNA synthesis company, today
announced the... |
| 10.12.2021 | Emergence Therapeutics raises €87 million Series A financing... | Duisburg, Germany, 7 December 2021. Emergence Therapeutics AG, a biopharmaceutical company developin... |
| 27.09.2021 | Hadean Ventures Announces the 1st Closing of EUR 90m for its... | - |
| 26.08.2021 | Cardior Raises €64 M Series B to Advance Clinical Pipeline o... | Oversubscribed round enables late-stage clinical development of lead
candidate, a micro-RNA-132 inh... |
| 08.07.2021 | Attgeno appoints Björn Westberg as CFO | Attgeno AB announces today that Björn Westberg has been appointed CFO
and member of the management ... |
| 29.06.2021 | SAGA Diagnostics raises €10.5 million | SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasens... |
| 29.06.2021 | Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Fu... | Norwegian radiopharmaceutical company announces successful closing of a
private placement that will... |
| 15.06.2021 | Gesynta Pharma announces significant progress across develop... | Stockholm, Sweden, June 14 2021
Gesynta Pharma announces significant progress across development pr... |
| 19.05.2021 | Abliva reports positive clinical Phase 1a/b results for KL13... | Abliva AB (Nasdaq Stockholm: ABLI), a clinical-stage biopharmaceutical company developing medicines ... |
| 30.04.2021 | Join Hadean Ventures! |
April 30, 2021
Hadean Ventures is a fast-growing life science fund manager that invests in compan... |
| 09.04.2021 | Safety Monitoring Committee Approves 7 MBq as Recommended Cl... | 7MBq dose of Radspherin® determined to be safe, and approved by the SMC as the recommended clinical ... |
| 24.03.2021 | Step Pharma Raises EUR35 Million in Series B Financing to Ad... | Archamps, France, 24 March 2021
Step Pharma, a biotech company developing novel drugs for oncology ... |
| 11.03.2021 | Oncoinvent Announces Progression of Radspherin® to Third Dos... | Oncoinvent Announces Progression of Radspherin® to Third Dose Level Cohort in Ongoing RAD-18-001 Pha... |
| 11.02.2021 | Pipeline Therapeutics Completes $80 Million Series C Financi... | Pipeline Therapeutics – News – 02/11/2021 |
| 05.02.2021 | Ekspertenes biotekfavoritter i urolige tider, e24.no | Etter snart ett år med børsoppgang, er det flere eksperter som spekulerer om vi står foran mer uroli... |
| 26.01.2021 | Gesynta Pharma initiates Phase II study of its first-in-clas... | Stockholm, Sweden, January 26, 2020 –
Gesynta Pharma AB today announced that the first
patients ha... |
| 21.01.2021 | Abliva appoints Ellen Donnelly as new CEO as they enter a ne... | Abliva appoints Ellen Donnelly as new CEO as it enters a new stage in its development – Abliva |
| 11.01.2021 | Oncoinvent Announces Advancement of Radspherin® to Final Dos... | Safety Monitoring Committee review of third dose-level cohort allows progression of Phase 1 RAD-18-0... |
| 03.01.2021 | Helsestartups får stryk på mangfold, e24.no | Helsestartups får stryk på mangfold – E24 av: Ina Vedde-Fjærestad |
| 01.12.2020 | Galecto Publishes GB0139 Phase 2a (IPF) Results in European ... | BOSTON and COPENHAGEN, Denmark, Nov. 30, 2020 (GLOBE NEWSWIRE) — Galecto, Inc., a NASDAQ listed biot... |
| 17.11.2020 | Abliva receives positive regulatory feedback from UK MHRA on... | Abliva AB (Nasdaq Stockholm: ABLI), a clinical-stage biopharmaceutical company developing medicines ... |
| 10.11.2020 | Abliva initiates a drug-drug interaction study and paves the... | Abliva AB (Nasdaq Stockholm: ABLI), a clinical-stage biopharmaceutical company developing medicines ... |
| 29.10.2020 | Oncoinvent Advances Radspherin® to Third Dose Level in Ongoi... | Safety review of second dose-level cohort allows study to advance to third cohort of colorectal canc... |
| 28.10.2020 | Galecto Announces Pricing of Initial Public Offering | BOSTON and COPENHAGEN, Denmark, Oct. 28, 2020 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a cli... |
| 22.10.2020 | Neuro Event Labs Receives FDA Breakthrough Device Designatio... | SAN ANTONIO (PRWEB) OCTOBER 22, 2020
Neuro Event Labs, Inc., a global diagnostic company, announced... |
| 08.10.2020 | Abliva doses the first patient in its KL1333 Phase Ia/b clin... | Abliva AB (Nasdaq Stockholm: ABLI) today announced that the first primary mitochondrial disease pati... |
| 25.09.2020 | Hadean Ventures invest in Galecto`s $64 million round equity... |
BOSTON and COPENHAGEN, Denmark, Sept. 25, 2020 (GLOBE NEWSWIRE) — Galecto, Inc., a privately-held ... |
| 14.09.2020 | Ingrid Teigland Akay included in Business Insider’s list of ... | - |
| 09.09.2020 | Abliva intends to start a pivotal KL1333 study second half 2... | - |
| 04.09.2020 | Oncoinvent Advances Radspherin[®] to Second Dose Level in On... | FRI, SEP 04, 2020 09:19 CET
Safety review of first dose-level cohort allows progression to second c... |
| 14.08.2020 | Pewin Member Highlight 2020: Ingrid Teigland Akay | - |
| 06.08.2020 | CardioMech AS Announces $18.5M Series A for its Transcathete... | The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investino... |
| 28.07.2020 | Abliva receives positive FDA feedback on its KL1333 developm... | - |
| 28.07.2020 | Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of... | SAN DIEGO, July 23, 2020 – Pipeline Therapeutics, a biopharmaceutical company focused on the develop... |
| 28.07.2020 | Gesynta raises SEK 190 million in round led by Hadean Ventur... | July 7, 2020, Stockholm |
| 18.06.2020 | €1.9M EU funding takes Nelli® available for all epilepsy pat... | Neuro Event Labs (NEL) will use €1.9M EU Horizon 2020 grant to become the standard of care in epilep... |
| 15.06.2020 | Abliva completes the directed issue of MSEK 20 to Hadean Ven... | On April 22, 2020, the Board of Directors of Abliva AB (publ) (“Abliva” or the “Company”) resolved, ... |
| 11.06.2020 | Oncoinvent Announces Dosing of First Patient with Radspherin... | Radiopharmaceutical company starts first-in-human trial in a second patient population; ovarian canc... |
| 02.06.2020 | Oncoinvent Announces Dosing of First Patient with Radspherin... | Press Release 02.2020: Radiopharmaceutical company starts first-in-human trial in colorectal patient... |
| 26.05.2020 | MSD to Acquire Themis | Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program O... |
| 22.04.2020 | NeuroVive makes a MSEK 20 directed share issue to leading No... | NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (”NeuroVive” or the ”Company”) has today decided... |
| 16.04.2020 | Varsler massive coronakjøp, Finansavisen | - |
| 09.04.2020 | Neuro Event Labs Oy closes EUR 3.9m Series A investment roun... | - |
| 20.03.2020 | Themis and Institut Pasteur Join Coronavirus Vaccine Hunt | The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — ha... |
| 18.12.2019 | Pipeline Therapeutics Completes $30 Million Series B Financi... | - |
| 27.11.2019 | Hadean Ventures receives Rising Star Award at the 10th editi... | Paris – Today Hadean Ventures won the Rising Star Award at the 10th edition of the Private Equity Ex... |
| 18.09.2019 | Hadean Ventures invests in Themis Bioscience GmbH EUR 40m Se... | - |
| 11.06.2019 | Hadean Ventures leads 40 million SEK (€3.7 million) investme... | LUND, Sweden and OSLO, Norway, June 11, 2019 — /B3C Newswire/ — SAGA Diagnostics AB, a precision onc... |
| 26.03.2019 | Level 20 selects Ingrid Teigland Akay as one of nine Inspiri... |
8th March 2019. In connection with the International Women’s Day, Level 20 released nine profiles ... |
| 26.03.2019 | Hadean Ventures’ Ingrid Teigland Akay receives Investor of t... | Oslo 6th March, 2019. Today Ingrid Teigland Akay, founder and managing partner at Hadean Ventures, r... |
| 06.11.2018 | Hadean Ventures is pleased to announce the appointment of Ro... |
Stockholm 01.11.2018. Hadean Ventures is pleased to announce the appointment of Roger Franklin PhD... |
| 13.07.2018 | Hadean Ventures, SINTEF Venture V and Investinor invest in N... | 13th July 2018, Oslo, Stockholm, Trondheim. Hadean Ventures today announced an investment in Nisonic... |
| 16.06.2018 | Investorview: Plugging knowledge gaps to accelerate life sci... | Investorview – Hadean Ventures 010618 |
| 22.05.2018 | Hadean Ventures today announces an investment in AttgeNO AB,... | 22nd May 2018, Stockholm, Oslo. Hadean Ventures today announces an investment in AttgeNO AB, a Swedi... |
| 18.12.2017 | Hadean Ventures launches new fund to leverage untapped poten... | 18.12.2017, Oslo, Stockholm – Hadean Ventures announced today the closing of Hadean Capital I, a
ne... |
